Rib-X Pharmaceuticals Inc., a developer of treatments for acute bacterial skin and skin structure infections, has closed the first tranche of a $67.5 million Series 2 preferred stock financing. A second tranche is expected to close around the end of 2012, the company said in a press release. New investor Vatera Healthcare Partners led the latest infusion, which included existing shareholders Warburg Pincus, ABS Ventures and Vox Equity Partners.
4 min read · 29 November 2012
Ginger.io, a San Francisco and Cambridge, Mass.-based maker of behavioral health analytics software, has closed a $6.5 million Series A round led by Khosla Ventures. Existing seed investors True Ventures and Romulus Capital also participated. Ginger.io's mobile application uses an individual's smartphone to identify changes in behavior that correlate with his or her health, the company says.
4 min read · 29 November 2012
Everything.me, the developer of a HTML5-based mobile app platform, has closed a $25 million Series C funding round. Telefónica Digital led the round. The Israel-based company, previously known as DoAT, is also backed by SingTel Innov8, Mozilla, Draper Fisher Jurvetson, DFJTF, BRM Group and Horizons Ventures.
5 min read · 29 November 2012
Wello, maker of an online two-way video training platform, has closed $1 million seed round, the company announced. Investors include "Rock Health investors from Kleiner Perkins, Mohr Davidow, Aberdare Ventures and Mayo Ventures, as well as Morado Ventures, S-Cubed Capital, PhilQuo Ventures" and undisclosed angel investors, the company said in a press release.
3 min read · 28 November 2012
AgilOne, a maker of cloud-based predictive marketing technology, has raised $10 million in Series B financing. Mayfield Fund led the round, with participation from Sequoia Capital. The company has raised a total of $16 million to date.
3 min read · 28 November 2012
TriReme Medical Inc., a developer of dilatation catheters, has raised $18 million in a new funding round led by Luminor Capital. TriReme is based in Based in Pleasanton, Calif., and Singapore.
2 min read · 28 November 2012
iSchool Campus has closed on $2 million in new financing from Crocker Ventures. The Series A round for the company is expected to reach $4 million, the company said. iSchool Campus, based in Utah, is a developer of systems to integrate mobile devices and other technology-based teaching tools across an entire school.
3 min read · 28 November 2012
Abrams Capital led a $36 million financing round for TransMedics Inc., a developer of organ preservation technology for transplantation. Existing investors including Flagship Ventures, Hercules Technology Growth Capital and Kleiner Perkins Caufield & Byers also participated.
2 min read · 28 November 2012
GlySure Limited, a developer of in-hospital continuous blood glucose monitoring systems, has closed on $13.6 million in Series C financing. The money will go toward clinical trials and regulatory clearance. Investors included Amadeus Capital Partners, Chester Investments, Delta Partners, Morningside Ventures and Frank Bonsal Jr., the company said.
2 min read · 28 November 2012
Biopharma startup Rhythm has closed on an additional $8 million in Series B financing to cap the round at $33 million. The newest infusion comes from Pfizer Venture Investments, the venture capital arm of Pfizer. Pfizer joins existing investors MPM Capital, New Enterprise Associates, Third Rock Ventures, and Ipsen. The money will go toward development of the company’s “small-peptide therapeutics” for metabolic diseases.
2 min read · 27 November 2012
